Runben Biotechnology
60319321.961.79% ( -0.40 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Runben Biotechnology(603193) the Revenue is 267.09 M (+11.27%);the EBIT is 51.84 M (+17.11%);the EPS is 0.13 (+18.18%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.27B11.27%
----
----
EBIT
0.05B17.11%
----
----
EPS
0.1318.18%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf